Walleye Capital
EHC icon

Walleye Capital’s Encompass Health EHC Stock Holding History

Walleye Capital’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-600
Closed -$60.8K – 4620
2025
Q1 		$60.8K Hold
600
– – ﹤0.01% 3789
2024
Q4 		$55.4K Sell
600
-4,800
-89% -$471K ﹤0.01% 4339
2024
Q3 		$522K Buy
+5,400
New +$485K ﹤0.01% 3262
2023
Q4 		– Sell
-2,400
Closed -$161K – 5083
2023
Q3 		$161K Buy
+2,400
New +$165K ﹤0.01% 3698
2020
Q1 		– Sell
-24,386
Closed -$1.34M – 1129
2019
Q4 		$1.34M Buy
+24,386
New +$1.32M 0.09% 314

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Walleye Capital's EHC Position: Q4 2025 in Review

Walleye Capital sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 3,810 shares — an estimated $484K sold.

Walleye Capital first reported a position in EHC in Q4 2019 and held it in 11 quarters. The position peaked at $800K in Q2 2025. 593 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

  • Walleye Capital reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 3,810 Encompass Health shares in Q4 2025, an estimated $484K.
  • Walleye Capital first reported a position in Encompass Health in Q4 2019 and held it in 11 quarters.
  • Walleye Capital's Encompass Health position peaked at $800K in Q2 2025.
  • 593 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.